Search

Your search keyword '"Asselbergs F, W"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Asselbergs F, W" Remove constraint Author: "Asselbergs F, W" Database OAIster Remove constraint Database: OAIster
129 results on '"Asselbergs F, W"'

Search Results

1. Influence of stressful life events and personality traits on PLN cardiomyopathy severity:an exploratory study

2. Influence of stressful life events and personality traits on PLN cardiomyopathy severity: an exploratory study

3. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

4. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity:an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

5. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

6. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

7. Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy

8. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

9. Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease

10. Patients with diffuse idiopathic skeletal hyperostosis have an increased burden of thoracic aortic calcifications

11. A polymorphism in Histidine-Rich Calcium Binding Protein as second hit in Phospholamban Cardiomyopathy

12. Missing data is poorly handled and reported in prediction model studies using machine learning: a literature review

13. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)

14. Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: Effectiveness and cost-effectiveness

15. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

16. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

17. The power of genetic diversity in genome-wide association studies of lipids

18. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

19. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

20. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

21. ONCOR:design of the Dutch cardio-oncology registry

22. BIO FOr CARE:biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

23. Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients

24. Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction:results from the CHECK-HF registry

26. Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium

27. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

28. BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants-design and status

29. Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry

30. ONCOR: design of the Dutch cardio-oncology registry

31. Sex-dependent gene regulation of human atherosclerotic plaques by DNA methylation and transcriptome integration points to smooth muscle cell involvement in women

32. Outcome of mechanical circulatory support at the University Medical Centre Utrecht

33. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial

34. Outcome of mechanical circulatory support at the University Medical Centre Utrecht

35. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial

36. Outcome of mechanical circulatory support at the University Medical Centre Utrecht

37. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial

38. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals

39. Outcome of mechanical circulatory support at the University Medical Centre Utrecht

40. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure: Design and rationale of the MONITOR HF multicentre randomised clinical trial

41. Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands : CVON-AI consortium

42. Cardiac amyloidosis : the need for early diagnosis

43. UNRAVEL : big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking

44. Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands : CVON-AI consortium

45. UNRAVEL : big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking

46. Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands : CVON-AI consortium

47. UNRAVEL : big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking

48. Cardiac amyloidosis : the need for early diagnosis

49. Associations of autozygosity with a broad range of human phenotypes

50. Cardiac amyloidosis: the need for early diagnosis

Catalog

Books, media, physical & digital resources